[Federal Register Volume 85, Number 131 (Wednesday, July 8, 2020)]
[Notices]
[Pages 41065-41066]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14623]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-681]


Importer of Controlled Substances Application: Xcelience

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before August 7, 2020. 
Such persons may also file a written request for a hearing on the 
application on or before August 7, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on May 28, 2020, Xcelience, 4901 West Grace Street, 
Tampa, Florida 33607-3805, applied to be registered as an Importer of 
the following basic class(es) of controlled substances:

------------------------------------------------------------------------
         Controlled  substance           Drug code        Schedule
------------------------------------------------------------------------
Psilocybin............................        7437  I
Amphetamine...........................        1100  II
------------------------------------------------------------------------

    The company plans to import drug code 7437 (Psilocybin), as bulk 
and drug code 1100 (Amphetamine), as finished dosage form for clinical 
trials, research, and analytical purposes. No other activity for drug 
code 1100 is authorized for this registration. Approval of permit

[[Page 41066]]

applications will occur only when the registrant's business activity is 
consistent with what is authorized under 21 U.S.C. 952(a)(2). 
Authorization will not extend to the import of the Food and Drug 
Administration-approved or non-approved finished dosage forms for 
commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-14623 Filed 7-7-20; 8:45 am]
BILLING CODE P